This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration | MicrobiomeTrials
← Back to trials NCT06970665
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-07-08Est. Completion: 2027-06-30
Enrollment target: 17 participantsLocations Nagoya City University Hospital, Nagoya, Aichi-ken, Japan Fukushima Medical University Hospital, Fukushima, Fukushima, Japan Kagawa University Hospital, Kita-gun, Kagawa-ken, Japan Yokohama City University Medical Center, Yokohama, Kanagawa, Japan Kyoto University Hospital, Kyoto, Kyoto, Japan Mie University Hospital, Tsu, Mie-ken, Japan Nagasaki University Hospital, Nagasaki, Nagasaki, Japan University of the Ryukyus hospital, Ginowan-shi, Okinawa, Japan Kansai Medical University Hospital, Hirakata-shi, Osaka, Japan The University of Osaka Hospital, Suita-shi, Osaka, Japan Seirei Hamamatsu General Hospital, Hamamatsu, Shizuoka, Japan Jichi Medical University Hospital, Shimotsuke-shi, Tochigi, Japan Nihon University Hospital, Chiyoda-ku, Tokyo, Japan Tokyo Women's Medical University Hospital, Shinjuku-ku, Tokyo, Japan Toyama University Hospital, Toyama, Toyama, Japan University Of Yamanashi Hospital, Chuo-shi, Yamanashi, Japan Other microbiome trials you might be interested in Geographic Atrophy (GA) Age - Related Macular Degeneration (AMD)
The purpose of this study is to collect efficacy and safety information of intravitreal injection for 3 experimental arm…
Gilbert, United States Est. completion Nov 2028
Geographic Atrophy Secondary to Age-related Macular Degeneration
To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-r…
Huntington Beach, United States Est. completion Aug 21, 2029